Join
Live feed
·
PRReleasevia Quantisnow
Rein Therapeutics Inc. logo

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis

ByQuantisnow·Wall Street's wire, on your screen.
RNTX· Rein Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNTX (Rein Therapeutics Inc.) and more on Quantisnow.